SCHEMBL3605747

SCHEMBL3605747

O=C(O)c1ccccc1-c1cc(-c2nnn[nH]2)c(-c2ccccc2C(=O)O)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
POLB P06746 2/20 0.38
ALDH1A1 P00352 5/20 0.36
RAB9A P51151 2/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
NPC1 O15118 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FOLH1 Q04609 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
DHODH Q02127 2/20 0.33
BRS3 P32247 1/20 0.33
HNF4A P41235 1/20 0.33
ESR1 P03372 2/20 0.33
MYC P01106 1/20 0.33
RECQL P46063 1/20 0.32
PTP4A3 O75365 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3598559 0.86 SLC6A3 (0.42) KDM4EALDH1A1TSHRHPGDMEN1
SCHEMBL4164810 0.82 KDM4E (0.50) KDM4EPOLBALDH1A1RAB9AUSP2
SCHEMBL3607514 0.79 IDO1 (0.36) ALDH1A1RAB9ANPC1SMN1; SMN2HPGD
SCHEMBL29649714 0.74 BRS3 (0.39) KDM4EPOLBRAB9ANPC1SMN1; SMN2
SCHEMBL3607451 0.74 ESR1 (0.41) KDM4EALDH1A1ESR1
SCHEMBL3606907 0.74 HDAC1 (0.44) KDM4EALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL3596652 0.74 NOTUM (0.42) KDM4EALDH1A1HPGDGAADHODH
SCHEMBL12496562 0.74 HSD17B1 (0.35) ESR1PTP4A3
SCHEMBL3604612 0.73 NPSR1 (0.42) KDM4EPOLBALDH1A1RAB9AUSP2
SCHEMBL3603427 0.72 MCL1 (0.41) KDM4EALDH1A1HPGDMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
US-20100048636-A1 Aspartic Protease Inhibitors VITAE PHARMACEUTICALS, INC. 2010-02-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048636-A1 Aspartic Protease Inhibitors DNPEP, PEPD, SERPINB1 KDM4E 2286/4885POLB 3415/4885ALDH1A1 1416/4885
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 KDM4E 4236/4885POLB 1277/4885ALDH1A1 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.